Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...
Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
The strategic insertion of the past is no longer incidental in Bollywood films. It has become a deliberate trope in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback